The Efficacy and Safety of Ramosetron in Patients Undergoing Off Pump Coronary Artery Bypass Surgery

NCT02139241 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Bypass Graft Triple Vessel
Hypotension

Interventions

DRUG: Ramosetron
DRUG: Normal saline

Sponsor

Seoul National University Hospital